Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Hyperarousal to Hyperglycemia: Therapeutic Targeting of Noradrenergic Signaling in PTSD-Related Insulin Resistance

NCT07862712 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT07862712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07862712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Hyperarousal to Hyperglycemia: Therapeutic Targeting of Noradrenergic Signaling in PTSD-Related Insulin Resistance
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
December 31, 2032
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome, posttraumatic stress disorder